Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-07-055892
Filing Date
2007-03-16
Accepted
2007-03-15 19:02:16
Documents
4
Period of Report
2007-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K d8ka.htm 8-K/A 14219
2 PRESS RELEASE dex991.htm EX-99.1 80540
3 CONFERENCE CALL TRANSCRIPT dex992.htm EX-99.2 52649
4 GRAPHIC g28699img01.jpg GRAPHIC 8032
  Complete submission text file 0001193125-07-055892.txt   160403
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 8-K/A | Act: 34 | File No.: 000-04829 | Film No.: 07697726
SIC: 2836 Biological Products, (No Diagnostic Substances)